Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for HeartSciences Inc. (HSCS : NSDQ)
 
 • Company Description   
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.

Number of Employees: 15

 
 • Price / Volume Information   
Yesterday's Closing Price: $3.57 Daily Weekly Monthly
20 Day Moving Average: 46,311 shares
Shares Outstanding: 1.08 (millions)
Market Capitalization: $3.86 (millions)
Beta: 2.57
52 Week High: $5.30
52 Week Low: $2.36
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.28% -4.71%
12 Week 3.48% -11.62%
Year To Date -6.54% -12.46%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
550 RESERVE ST SUITE 360
-
SOUTHLAKE,TX 76092
USA
ph: 682-237-7781
fax: -
investorrelations@heartsciences.com https://heartsciences.com
 
 • General Corporate Information   
Officers
Andrew Simpson - President; Chief Executive Officer and Chairman
Mark Hilz - Chief Operating Officer; Secretary and Director
Danielle Watson - Chief Financial Officer and Treasurer
Bruce Bent - Director
David R. Wells - Director

Peer Information
HeartSciences Inc. (HLIS)
HeartSciences Inc. (AZTA)
HeartSciences Inc. (APYI)
HeartSciences Inc. (RNVA)
HeartSciences Inc. (HMSY)
HeartSciences Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 42254E302
SIC: 3842
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 01/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 1.08
Most Recent Split Date: 5.00 (0.01:1)
Beta: 2.57
Market Capitalization: $3.86 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-2.41 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-9.78 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.96
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 14.33%
vs. Previous Quarter: -13.22%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
04/30/25 - -
01/31/25 - -178.80
10/31/24 - -117.76
ROA
04/30/25 - -
01/31/25 - -109.28
10/31/24 - -84.09
Current Ratio
04/30/25 - -
01/31/25 - 1.02
10/31/24 - 1.72
Quick Ratio
04/30/25 - -
01/31/25 - 0.83
10/31/24 - 1.52
Operating Margin
04/30/25 - -
01/31/25 - -
10/31/24 - -
Net Margin
04/30/25 - -
01/31/25 - -
10/31/24 - -
Pre-Tax Margin
04/30/25 - -
01/31/25 - -
10/31/24 - -50,833.34
Book Value
04/30/25 - -
01/31/25 - 1.82
10/31/24 - 4.40
Inventory Turnover
04/30/25 - -
01/31/25 - 0.00
10/31/24 - 0.01
Debt-to-Equity
04/30/25 - -
01/31/25 - 0.00
10/31/24 - 0.01
Debt-to-Capital
04/30/25 - -
01/31/25 - 0.00
10/31/24 - 1.22
 

Powered by Zacks Investment Research ©